Stock VACC NYKODE THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Nykode Therapeutics

Equities

VACC

NO0010714785

Market Closed - Oslo Bors
Other stock markets
 15:45:00 29/04/2024 BST 		5-day change 1st Jan Change
13.24 NOK +2.00% Intraday chart for Nykode Therapeutics +0.61% -38.13%
04-19 Nykode Therapeutics Launches Phase 2 Clinical Trial for Cervical Cancer Vaccine MT
04-19 Nykode Therapeutics ASA Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer CI

Evolution of the average Target Price on Nykode Therapeutics

Price target over the last 5 years

History of analyst recommendation changes

0f6a57e2d.KAOrdK1d4w4rGb60YsrVooEdyneuFhjxUt_9LB3XkLg.e07aEfU8qkBgKOniMq2lmt5-r0bnLk6IJrGlFHSa2vNAWf8m7hrXREdY7w~fb3d463d9365436bacd0d63cf05f4b32

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
13.24 NOK
Average target price
43 NOK
Spread / Average Target
+224.77%
High Price Target
70 NOK
Spread / Highest target
+428.70%
Low Price Target
28 NOK
Spread / Lowest Target
+111.48%

Consensus detail

Consensus revision (last 18 months)

Ratings for Nykode Therapeutics

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. VACC Stock
  4. Consensus Nykode Therapeutics